Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Champions Oncology (CSBR) Long-Term Debt Repayments (2016 - 2020)

Champions Oncology (CSBR) has 6 years of Long-Term Debt Repayments data on record, last reported at -$16000.0 in Q2 2020.

  • For Q2 2020, Long-Term Debt Repayments fell 107.66% year-over-year to -$16000.0; the TTM value through Apr 2020 reached $35000.0, down 86.64%, while the annual FY2020 figure was $35000.0, 86.64% down from the prior year.
  • Long-Term Debt Repayments reached -$16000.0 in Q2 2020 per CSBR's latest filing, down from $37000.0 in the prior quarter.
  • Across five years, Long-Term Debt Repayments topped out at $209000.0 in Q2 2019 and bottomed at -$16000.0 in Q2 2020.
  • Average Long-Term Debt Repayments over 5 years is $19944.4, with a median of $6500.0 recorded in 2016.
  • Peak YoY movement for Long-Term Debt Repayments: skyrocketed 3383.33% in 2019, then crashed 107.66% in 2020.
  • A 5-year view of Long-Term Debt Repayments shows it stood at $6000.0 in 2016, then changed by 0.0% to $6000.0 in 2017, then skyrocketed by 450.0% to $33000.0 in 2018, then plummeted by 78.79% to $7000.0 in 2019, then tumbled by 328.57% to -$16000.0 in 2020.
  • Per Business Quant database, its latest 3 readings for Long-Term Debt Repayments were -$16000.0 in Q2 2020, $37000.0 in Q1 2020, and $7000.0 in Q4 2019.